$ABEO 8-K/A SEC Filings

Filed On	Filing
28 May 2021	8-K/A: Departure/Election of Directors or Officers; Compensation On April 19, 2021, Abeona Therapeutics Inc. (the “Company”) filed a Current Report on Form 8-K disclosing under Item 5.02 that Leila Alland, M.D. and Donald Wuchterl were appointed to serve on the Board of Directors (the “Board”) of the ...
09 Oct 2018	8-K/A: Departure/Election of Directors or Officers; Compensation
14 May 2018	8-K/A: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
04 Jun 2015	8-K/A: Financial Statements and Exhibits
13 May 2015	8-K/A: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation
27 Apr 2015	8-K/A: Unregistered Sales of Equity Securities; Other Events
26 Aug 2009	8-K/A: Financial Statements and Exhibits
22 Sep 2008	8-K/A: Financial Statements and Exhibits
17 Jun 2008	8-K/A: Financial Statements and Exhibits
23 Apr 2007	8-K/A: Entry into a Material Definitive Agreement; Other Events
16 Nov 2004	8-K/A: Results of Operations and Financial Condition
04 Oct 1999	8-K/A: Completion of Acquisition or Disposition of Assets

Comments